In neurological diseases such as AD and TBI, the expression of TGF-β and its signaling components in the neurovasculature is altered, leading to dysregulated TGF-β signaling and subsequent BBB dysfunction [84]. The gene discussed is TGFB1; the disease is nervous system disorder.